Tracking AVBP? Get live short interest, options flow, and signals on ORTEX.Sign up free →

ArriVent BioPharma, Inc. (AVBP) short interest & options flow

NASDAQ

AVBP arrives at its November 10 earnings report with a sharply divided market. Short sellers have been covering aggressively, the stock has rebounded off its October lows, and the analyst community just received a catalyst-driven jolt. The core question heading into the print is whether firmonertinib's story has enough life left to justify the recovery. The most striking shift in…

$13.51+0.11% 1d+0.11% 1w-19.28% 1mClose: 11 Nov 2026

Short interest % of float: High; Live SI on ORTEX →
Cost to borrow: Low and dropping; Live CTB on ORTEX →
Availability: Dropping; Live availability on ORTEX →

Market cap: $699M
Next earnings: 3 Mar 2027

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of ArriVent BioPharma, Inc. (AVBP) share price and short interest (% of free float), six months to November 11, 2026

AVBP news and analysis

RSS

No long-form analysis yet for AVBP. Pulse alerts and the live data picture are available on ORTEX.

Open AVBP on ORTEX →

Want the live picture for AVBP?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AVBP — free to start on ORTEX.

We value your privacy

AVBP news and analysis

Want the live picture for AVBP?